Back
The Goldman Sachs Group Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
82
GS
The Goldman Sachs Group
Last Price:
459.36
Seasonality Move:
3.77%
Sell
44
FDMT
4D Molecular Therapeutics
Last Price:
25.96
Seasonality Move:
-0.46%
Buy
82
The Goldman Sachs Group (GS)
is a Buy
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $453.56. The Score for GS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- GS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
44
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $25.57. The Score for FDMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $453.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $25.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
GS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.7 | Buy |
Relative Strength Index (14 RSI): | 74.4 | Buy |
Chaikin Money Flow: | -1381813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (403.29 - 442.53) | Buy |
Bollinger Bands (100): | (377.95 - 417.37) | Buy |
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 45.76 | Sell |
Chaikin Money Flow: | -384368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.51 - 26.83) | Sell |
Bollinger Bands (100): | (20.52 - 30.14) | Buy |
GS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 446.13 | Buy |
20-day SMA: | 428.67 | Buy |
50-day SMA: | 411.2 | Buy |
200-day SMA: | 363.78 | Buy |
8-day EMA: | 446.25 | Buy |
20-day EMA: | 432.99 | Buy |
50-day EMA: | 415.55 | Buy |
200-day EMA: | 376.94 | Buy |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.18 | Sell |
20-day SMA: | 25.37 | Buy |
50-day SMA: | 28.05 | Sell |
200-day SMA: | 19.6 | Buy |
8-day EMA: | 25.79 | Sell |
20-day EMA: | 26 | Sell |
50-day EMA: | 26.41 | Sell |
200-day EMA: | 21.96 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.26 per share, an increase next quarter of $1.15 per share, an increase this year of $13.91 per share, and an increase next year of $3.47 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.
The Goldman Sachs Group Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
4D Molecular Therapeutics Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |